CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets

Read the official FDA notice

Published
15 Oct 2025
Units affected
54,432 bottles
Agency
FDA
Country
United States

The hazard

Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.

Brand / company
ACCORD HEALTHCARE, INC.
Codes / lots
Lot # D2300045, Exp 12/31/2025.
Distribution
Nationwide in the US
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 15 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.